Literature DB >> 9236233

Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction.

N C Day1, S J Wood, P G Ince, S G Volsen, W Smith, C R Slater, P J Shaw.   

Abstract

Neurotransmitter release is regulated by voltage-dependent calcium channels (VDCCs) at synapses throughout the nervous system. At the neuromuscular junction (NMJ) electrophysiological and pharmacological studies have identified a major role for P- and/or Q-type VDCCs in controlling acetylcholine release from the nerve terminal. Additional studies have suggested that N-type channels may be involved in neuromuscular transmission. VDCCs consist of pore-forming alpha1 and regulatory beta subunits. In this report, using fluorescence immunocytochemistry, we provide evidence that immunoreactivity to alpha1A, alpha1B, and alpha1E subunits is present at both rat and human adult NMJs. Using control and denervated rat preparations, we have been able to establish that the subunit thought to correspond to P/Q-type channels, alpha1A, is localized presynaptically in discrete puncta that may represent motor nerve terminals. We also demonstrate for the first time that alpha1A and alpha1B (which corresponds to N-type channels) may be localized in axon-associated Schwann cells and, further, that the alpha1B subunit may be present in perisynaptic Schwann cells. In addition, the alpha1E subunit (which may correspond to R/T-type channels) seems to be localized postsynaptically in the muscle fiber membrane and concentrated at the NMJ. The possibility that all three VDCCs at the NMJ are potential targets for circulating autoantibodies in amyotrophic lateral sclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236233      PMCID: PMC6568369     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Different distributions of dystrophin and related proteins at nerve-muscle junctions.

Authors:  G S Bewick; L V Nicholson; C Young; E O'Donnell; C R Slater
Journal:  Neuroreport       Date:  1992-10       Impact factor: 1.837

2.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES.

Authors:  M J KARNOVSKY; L ROOTS
Journal:  J Histochem Cytochem       Date:  1964-03       Impact factor: 2.479

3.  A novel omega-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction.

Authors:  Y Sugiura; A Woppmann; G P Miljanich; C P Ko
Journal:  J Neurocytol       Date:  1995-01

4.  Effects of synthetic omega-conotoxin, a new type Ca2+ antagonist, on frog and mouse neuromuscular transmission.

Authors:  K Sano; K Enomoto; T Maeno
Journal:  Eur J Pharmacol       Date:  1987-09-11       Impact factor: 4.432

5.  Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins.

Authors:  O Delbono; J García; S H Appel; E Stefani
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

6.  omega-Conotoxin GVIA binds to and blocks rat neuromuscular junction.

Authors:  G Rossoni; F Berti; L La Maestra; F Clementi
Journal:  Neurosci Lett       Date:  1994-08-01       Impact factor: 3.046

7.  Neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  R A Maselli; R L Wollman; C Leung; B Distad; S Palombi; D P Richman; E F Salazar-Grueso; R P Roos
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

8.  Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle.

Authors:  J R Sanes; J M Cheney
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

9.  Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.

Authors:  S S Bowersox; G P Miljanich; Y Sugiura; C Li; L Nadasdi; B B Hoffman; J Ramachandran; C P Ko
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

10.  Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin omega-Aga-IVA.

Authors:  D A Protti; O D Uchitel
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

View more
  28 in total

1.  Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit.

Authors:  K Jun; E S Piedras-Rentería; S M Smith; D B Wheeler; S B Lee; T G Lee; H Chin; M E Adams; R H Scheller; R W Tsien; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Glycerotoxin from Glycera convoluta stimulates neurosecretion by up-regulating N-type Ca2+ channel activity.

Authors:  Frédéric A Meunier; Zhong-Ping Feng; Jordi Molgó; Gerald W Zamponi; Giampietro Schiavo
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

Review 3.  Molecular mechanism of active zone organization at vertebrate neuromuscular junctions.

Authors:  Hiroshi Nishimune
Journal:  Mol Neurobiol       Date:  2011-12-02       Impact factor: 5.590

Review 4.  Exploring the central modulation hypothesis: do ancient memory mechanisms underlie the pathophysiology of trigger points?

Authors:  Mark J L Hocking
Journal:  Curr Pain Headache Rep       Date:  2013-07

Review 5.  Metabolism and trafficking of N-type voltage-operated calcium channels in neurosecretory cells.

Authors:  E Sher; P Rosa; M Francolini; A Codignola; E Morlacchi; E Taverna; F Giovannini; A Brioschi; F Clementi; M W McEnery; M Passafaro
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

6.  Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals.

Authors:  R E Westenbroek; L Hoskins; W A Catterall
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

7.  Revealing of T-type low-voltage activated calcium channels (CaV3) in frog neuromuscular junctions.

Authors:  L F Nurullin; A N Tsentsevitsky; A I Malomouzh; E E Nikolsky
Journal:  Dokl Biol Sci       Date:  2013-05-08

8.  Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.

Authors:  F Giovannini; E Sher; R Webster; J Boot; B Lang
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 9.  Active zones of mammalian neuromuscular junctions: formation, density, and aging.

Authors:  Hiroshi Nishimune
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 10.  The ataxic Cacna1a-mutant mouse rolling nagoya: an overview of neuromorphological and electrophysiological findings.

Authors:  Jaap J Plomp; Arn M J M van den Maagdenberg; Simon Kaja
Journal:  Cerebellum       Date:  2009-05-30       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.